Literature DB >> 15122806

Production of interferon gamma in respiratory syncytial virus infection of humans is not associated with interleukins 12 and 18.

Roberto P Garofalo1, Karen H Hintz, Vanessa Hill, Pearay L Ogra, Robert C Welliver.   

Abstract

In order to understand early events in the immune response to respiratory syncytial virus (RSV) infection, we studied the presence of various chemokines and cytokines in respiratory secretions of human infants with RSV infection. Interferon gamma (IFNgamma) was present in 30/39 (76.9%) subjects tested, but the IFNgamma-inducing cytokines interleukin (IL)12 and IL18 were detectable in 6/40 (15%) and 11/38 (28.9%) subjects, respectively. Quantities of IL12 and IL18 did not correlate with those of IFNgamma. IL18, but neither IFNgamma nor IL12 was found in significantly greater concentrations in subjects with mild, nonhypoxic forms of bronchiolitis than in those with upper respiratory illness alone or hypoxic bronchiolitis. The findings suggest that IFNgamma may be induced independently of the activities of IL12 and IL18 during RSV infection. Immune responses characterized by relatively greater release of IL18 may be associated with milder forms of bronchiolitis. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15122806     DOI: 10.1002/jmv.20089

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  15 in total

Review 1.  Pathogenesis of respiratory syncytial virus infection in the murine model.

Authors:  R Stokes Peebles; Barney S Graham
Journal:  Proc Am Thorac Soc       Date:  2005

2.  Mucosal inoculation with an attenuated mouse pneumovirus strain protects against virulent challenge in wild type and interferon-gamma receptor deficient mice.

Authors:  John A Ellis; Brittany V Martin; Cheryl Waldner; Kimberly D Dyer; Joseph B Domachowske; Helene F Rosenberg
Journal:  Vaccine       Date:  2006-10-12       Impact factor: 3.641

Review 3.  Nasal cytokines as mediators of illness during the common cold.

Authors:  William J Doyle; David P Skoner; Deborah Gentile
Journal:  Curr Allergy Asthma Rep       Date:  2005-05       Impact factor: 4.806

4.  Respiratory syncytial virus is associated with an inflammatory response in lungs and architectural remodeling of lung-draining lymph nodes of newborn lambs.

Authors:  Fatoumata B Sow; Jack M Gallup; Alicia Olivier; Subramaniam Krishnan; Andriani C Patera; JoAnn Suzich; Mark R Ackermann
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-10-08       Impact factor: 5.464

Review 5.  Human genetic factors and respiratory syncytial virus disease severity.

Authors:  Isao Miyairi; John P DeVincenzo
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

Review 6.  Epidemiologic, experimental, and clinical links between respiratory syncytial virus infection and asthma.

Authors:  Shyam S Mohapatra; Sandhya Boyapalle
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

7.  Sustained inflammation and differential expression of interferons type I and III in PVM-infected interferon-gamma (IFNγ) gene-deleted mice.

Authors:  Stephanie F Glineur; Aaron B Bowen; Caroline M Percopo; Katia E Garcia-Crespo; Kimberly D Dyer; Sergei I Ochkur; Nancy A Lee; James J Lee; Joseph B Domachowske; Helene F Rosenberg
Journal:  Virology       Date:  2014-08-28       Impact factor: 3.616

8.  Differential recruitment of dendritic cells and monocytes to respiratory mucosal sites in children with influenza virus or respiratory syncytial virus infection.

Authors:  Michelle A Gill; Kristin Long; Theresa Kwon; Luz Muniz; Asuncion Mejias; John Connolly; Lonnie Roy; Jacques Banchereau; Octavio Ramilo
Journal:  J Infect Dis       Date:  2008-12-01       Impact factor: 5.226

Review 9.  Respiratory syncytial virus--a comprehensive review.

Authors:  Andrea T Borchers; Christopher Chang; M Eric Gershwin; Laurel J Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2013-12       Impact factor: 8.667

Review 10.  The Human Immune Response to Respiratory Syncytial Virus Infection.

Authors:  Clark D Russell; Stefan A Unger; Marc Walton; Jürgen Schwarze
Journal:  Clin Microbiol Rev       Date:  2017-04       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.